OPTIMAL-DIABETES
2026
OPTIMAL-DIABETES: Intensive Blood Pressure Control for Reduction of Major Cardiovascular Events in Patients With Diabetes Mellitus
In adults with type 2 diabetes at increased cardiovascular risk, an intensive systolic blood pressure target did not significantly reduce major cardiovascular events compared with a standard systolic target.
Resultado
- Diferencia absoluta
- 0,7 puntos
about a 10% lower risk10
La diferencia absoluta se deriva de las tasas de eventos.
También se informa: That was not statistically significant. Kidney-related events, primarily declines in kidney function, occurred in 270 participants (5.7%) vs 175 participants (3.7%), about 55% higher with intensive treatment. End-stage renal disease was similar between groups. Serious adverse events were similar between groups. Systolic blood pressure during follow-up was 122 mm Hg vs 135 mm Hg.
- Subtema
- Intensive BP targets
- Diseño
- Pragmatic, multicentre randomised trial with blinded outcome assessment (Hospital Israelita Albert Einstein; 32 Brazilian sites); systolic target below 120 mmHg versus below 140 mmHg in type 2 diabetes at high cardiovascular risk, follow-up to 48 months
- Incluidos
- 9476 pacientes
- Fuente
- Santo K, Martins E, Silva GS, et al. N Engl J Med. 2026; published online 7 November.doi 10.1056/nejmoa2612922
Discusión y crítica
This large randomised trial found that an intensive systolic target did not significantly reduce major cardiovascular events in people with type 2 diabetes. Kidney-related events were more frequent with intensive treatment, although they were mainly declines in kidney function and end-stage renal disease did not differ. The trial was open-label and was run only in Brazil, which the investigators say may limit generalisability. The newsroom release gives no hazard ratio, confidence interval or P value for the primary endpoint, so the precision of the estimate cannot be judged from this source.